A Patient of Anti-phospholipid Syndrome and Pulmonary Tuberculosis with Cor Pulmonale: A Case Report and Prospective Treatment

Zon-Min Lee, Ping-yu Lee, Cheng Cheng
{"title":"A Patient of Anti-phospholipid Syndrome and Pulmonary Tuberculosis with Cor Pulmonale: A Case Report and Prospective Treatment","authors":"Zon-Min Lee, Ping-yu Lee, Cheng Cheng","doi":"10.7019/TPJ.200812.0007","DOIUrl":null,"url":null,"abstract":"A 27-year-old male presented with progressive dyspnea and productive cough with whitish sputum for several months. Severe central and peripheral cyanosis and leg edema were also noted. Right heart failure was diagnosed based on echocardiograph findings, and pulmonary thromboembolism was suspected due to elevated D-dimer level. Anti-phospholipid syndrome was diagnosed based on the elevation of anti-cardiolipin immunoglobulin G, and nifedipine, enoxaparin, furosemide, and continuous oxygen were given as initial treatment. Bilateral pulmonary fibrothorax was noted on Chest X-ray, and pulmonary tuberculosis was confirmed by positive sputum acid fast stain. The patient was discharged with improvement in dyspnea and cyanosis after isolation for anti-tuberculosis medication. Finally, his condition improved significantly during the year following hospitalization, and pulmonary artery pressure returned to normal after the complete anti-tuberculosis treatment course and long-term oral anticoagulant treatment. Consequently, prompt diagnosis and appropriate medication, including anti-TB medication, anticoagulant drug, and continuous oxygen, are essential to improve clinical prognosis of cor pulmonale due to reversible etiologies such as pulmonary tuberculosis and chronic pulmonary thromboembolism.","PeriodicalId":22409,"journal":{"name":"The Chinese Pharmaceutical Journal","volume":"25 1","pages":"7-11"},"PeriodicalIF":0.0000,"publicationDate":"2008-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Chinese Pharmaceutical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7019/TPJ.200812.0007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

A 27-year-old male presented with progressive dyspnea and productive cough with whitish sputum for several months. Severe central and peripheral cyanosis and leg edema were also noted. Right heart failure was diagnosed based on echocardiograph findings, and pulmonary thromboembolism was suspected due to elevated D-dimer level. Anti-phospholipid syndrome was diagnosed based on the elevation of anti-cardiolipin immunoglobulin G, and nifedipine, enoxaparin, furosemide, and continuous oxygen were given as initial treatment. Bilateral pulmonary fibrothorax was noted on Chest X-ray, and pulmonary tuberculosis was confirmed by positive sputum acid fast stain. The patient was discharged with improvement in dyspnea and cyanosis after isolation for anti-tuberculosis medication. Finally, his condition improved significantly during the year following hospitalization, and pulmonary artery pressure returned to normal after the complete anti-tuberculosis treatment course and long-term oral anticoagulant treatment. Consequently, prompt diagnosis and appropriate medication, including anti-TB medication, anticoagulant drug, and continuous oxygen, are essential to improve clinical prognosis of cor pulmonale due to reversible etiologies such as pulmonary tuberculosis and chronic pulmonary thromboembolism.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
抗磷脂综合征合并肺心病肺结核1例报告及前瞻性治疗
男性,27岁,进行性呼吸困难,咳痰发白数月。严重的中央和外周发绀和腿部水肿也被注意到。根据超声心动图结果诊断为右心衰,由于d -二聚体水平升高,怀疑肺血栓栓塞。根据抗心磷脂免疫球蛋白G升高诊断为抗磷脂综合征,给予硝苯地平、依诺肝素、速尿、持续供氧作为初始治疗。胸部x线示双侧肺纤维胸,痰抗酸染色阳性证实为肺结核。患者在隔离抗结核药物治疗后呼吸困难和发绀改善出院。最后,在住院一年内病情明显好转,在完成抗结核疗程和长期口服抗凝治疗后,肺动脉压恢复正常。因此,及时诊断和适当的药物治疗,包括抗结核药物、抗凝药物和持续吸氧,对于改善由可逆性病因(如肺结核和慢性肺血栓栓塞)引起的肺心病的临床预后至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Research Progress of Pharmacokinetic Interactions between Lopinavir/Ritonavir and Statins Results and Discussion on National Vaccine Proficiency Testing Schemes in 2020 Case Study of Icotinib on The Impact of Domestic Innovative Drugs Timely Covered by Medical Insurance Evaluation of α-Interferon Applied in COVID-19 Therapy Regimen Detection and Analysis of Safety Signals of Chloroquine Based Upon FDA Adverse Event Database
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1